Skip to main content
Premium Trial:

Request an Annual Quote

Vitra Introduces New Application for CellCard System

NEW YORK, Jan. 24 (GenomeWeb News) - Expanding its technologic product offering, Vitra Bioscience has made a nuclear translocation application available for its CellCard system for conducting highly multiplexed cell-based assays in high-content drug screening, the company said today.


According to the Mountain View, Calif.-based company, nuclear translocation is an important measure of cellular response to various drug therapies. Key proteins that undergo translocation are targets for anti-inflammatory drugs, while potential inhibitors of these proteins may have therapeutic benefits in treating cancer, Vitra said.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.